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Abstract
Background: Solid pseudopapillary neoplasm is a rare cystic tumor of the exocrine pancreas. Abdominal pain or
discomfort is the most common symptom, usually in young females.
Case presentation: Herein we report the case of an 8 - year old child presenting with symptoms of gastric outlet
obstruction.
Conclusion: A solid pseudopapillary neoplasm of the pancreatic caput was diagnosed and surgically removed.
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Background
Solid pseudopapillary neoplasm (SPN) is a rare cystic
tumor of exocrine pancreas with a female predominance.
Clinically, it presents as a mass in the pancreas with a
wide range of symptoms. Surgical exploration is indi-
cated to release the intra-abdominal extrusion and for
histopathology. SPN to the best of our knowledge has so
far not been reported in patients below 9 years of age.
Besides, gastric outlet obstruction has not been reported
as the first sign of SPN.
Case presentation
An 8-year old female patient presented in the pediatric
unit with abdominal discomfort, nausea and bitter vom-
itus. Physical examination revealed a mass in the abdo-
men. Abdominal ultrasound sonography revealed a 3 cm
large mass in the head of the pancreas. Endoscopic sonog-
raphy confirmed a cystic tumor of the pancreatic caput
and fine needle biopsies were taken for histopathology,
Fig. 1a & b. Blood chemistry revealed elevated c-reactive
protein (CRP: 7.2 mg/dl; normal range <0.5 mg/dl) and
high white blood count (WBC: 16.2/nl; normal range:
4–10/nl). Serum lipase was mildly elevated (179 U/l;
normal range: < 60 U/l). All liver enzymes including
bilirubin were within normal range. Equally, the tumor
markers carbohydrate antigen 19–9 (CA 19–9), carci-
noembryonic antigen (CEA) and chromogranin A were
within normal limits.
Magnet resonance imaging (MRI) of the abdomen
showed a thick-walled, cystic mass in the head of the
pancreas with compression of the duodenum, Fig. 2a–c.
Histopathology from the fine needle biopsies was incon-
clusive. The case was discussed at the interdisciplinary
board and surgical exploration was recommended.
A well capsulated mass of the pancreatic head without
macroscopic signs of malignancy was found and com-
pletely enucleated during laparotomy, Fig. 3. Surgery
and recovery were uneventful and the patient was dis-
charged 7 days later with normal pancreatic function.
Histopathology confirmed the diagnosis of SPN fol-
lowing positive stains on immunohistochemistry with
antitrypsin, vimentin, beta-catenin, CD 56 and CD
10, Fig. 4a–f.* Correspondence: peter.ambe@helios-kliniken.de1Helios Klinikum Wuppertal, Department of Surgery II, Witten – Herdecke
University, 42283 Wuppertal, Germany
Full list of author information is available at the end of the article
© 2016 Bidassek et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Bidassek et al. Diagnostic Pathology  (2016) 11:7 
DOI 10.1186/s13000-016-0465-7
Discussion
SPN of the pancreas was first reported by Lichtenstein
in 1934 [1]. In 1996 SPN was recognized by the World
Health Organization as an independent histopathologic
entity.
The incidence of SPN varies widely amongst reported
series. Cubilla and Fitzerald [2] reported a 0.17 % inci-
dence for SPN in a series of 645 pancreatic neoplasms.
Morohoshi et al. [3] reported seven cases of SPN (2.7 %)
after analyzing 264 pancreatic tumors. In yet another
series of 336 cases, 1.48 % incidence of SPN was reported
by Sheeham and colleagues [4]. Because all these inci-
dences are based on adult or mixed population, the inci-
dence of SPN in the pediatric population is estimated to
be way below the 0.17 % reported by Cubilla and Fitzerald
[2]. This notion is supported a report by Lack et al., who
found just one case of SPN in a 30 - year review of data
from the Boston Children’s Hospita [5].
The limited amount of publications on SNP is a re-
flection of the rare nature of this entity. In fact, a
vast majority of the medical literature on this entity
consists of case reports and small case series. The lar-
gest series so far is a review by Papavramidis et al.
[6] including 718 cases. In this series, the prevalence
of SPN was higher in female patients with a female
to male ration of 10:1. The mean age at the time of
diagnosis in this series was 22 years. Although an age
range from 2 to 84 years was reported in their re-
view, no single publication on SPN in a patient below
the age of 9 years could be found in the English
literature.
Although SPN can be clinically silent, patients might
present with a mass in the upper abdomen with discom-
fort or pain [7]. Physical examination may reveal a mass
in the mid abdomen. This is usually seen on ultrasound
sonography. Endoscopic sonography with fine needle
biopsy for histopathology might be helpful. The tumor is
usually identified on MRI or computed tomography.
Surgical exploration and resection is the mainstay of
treatment [8, 9]. Surgical excision is directed towards
Fig. 1 Findings from ultrasound sonography. a trans abdominal ultrasound sonography showing a mass in the pancreatic caput. b endoscopic
sonography of the pancreas confirmed a large mass in the head of the pancreas
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symptom relief as well as to confirm the on histopath-
ology and role out other malignant pancreatic lesions.
On like in other reports, signs of gastric outlet obstruc-
tion, i.e. mechanical obstruction of the upper gastro-
intestinal tract with recurrent bitter vomitus in this case
heralded SPN. Although no enzymatic analysis of the
vomitus for bile of gastric enzymes was performed, the
bitter nature of the vomitus suggested a proximal gastro-
intestinal obstruction. This was confirmed by the identifi-
cation of a large mass in the pancreatic head with duodenal
compression (Fig. 3). A well-encapsulated mass of the
pancreatic caput was completely enucleated during surgi-
cal exploration. Histopathology and immunohistochemis-
try confirmed the mass to be an SPN.
There are two distinctive findings in this case: the age
at the time of presentation and the initial symptom. This
to the best of our knowledge is the first reported case of
SPN in a patient below nine years. The child in this case
was eight years old at the time of diagnosis and gas-
tric outlet obstruction has not been previously re-
ported as an initial presentation of SPN.
Conclusion
Taken together, this is the first reported case of SPN in a
child below the age of nine presenting with bitter
Fig. 2 MRI scans in coronary. * SPN. a sagittal b tranversal c reconstruction
Fig. 3 Intraoperative finding
Bidassek et al. Diagnostic Pathology  (2016) 11:7 Page 3 of 5
vomitus as a sign of gastric outlet obstruction. An inter-
disciplinary board should discuss all such cases. Surgical
exploration with the goal of releasing symptoms is the
main stay of treatment. Although SPN is mostly benign,
there is a minimal risk of malignant transformation.
Therefore, histopathology with immunohistochemical
staining should be performed to confirm the diagnosis
of SPN and role out malignant pancreatic tumors.
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